...
首页> 外文期刊>Molecular and Cellular Endocrinology >Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells
【24h】

Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells

机译:鉴定与乳腺癌细胞早期和晚期细胞周期事件相关的成纤维细胞生长因子8b靶基因

获取原文
获取原文并翻译 | 示例

摘要

Fibroblast growth factor-8 (FGF-8) is implicated in the development and progression of breast cancer and its levels are frequently elevated in breast tumors. The mechanisms driving FGF-8-mediated tumorigenesis are not well understood. Herein we aimed to identify target genes associated with FGF-8b-mediated breast cancer cell proliferation by carrying out a cDNA microarray analysis of genes expressed in estrogen receptor negative S115 breast cancer cells treated with FGF-8b for various time periods in comparison with those expressed in non-treated cells. Gene and protein expression was validated for selected genes by qPCR and western blotting respectively. Furthermore, using TRANSBIG data, the expression of human orthologs of FGF-8-regulated genes was correlated to the Nottingham prognostic index and estrogen receptor status. The analysis revealed a number of significantly up- and down-regulated genes in response to FGF-8b at all treatment times. The most differentially expressed genes were genes related to cell cycle regulation, mitosis, cancer, and cell death. Several key regulators of early cell cycle progression such as Btg2 and cyclin D1, as well as regulators of mitosis, including cyclin B, Plk1, survivin, and aurora kinase A, were identified as novel targets for FGF-8b, some of which were additionally shown to correlate with prognosis and ER status in human breast cancer. The results suggest that in stimulation of proliferation FGF-8b not only promotes cell cycle progression through the G1 restriction point but also regulates key proteins involved in chromosomal segregation during mitosis and cytokinesis of breast cancer cells.
机译:成纤维细胞生长因子8(FGF-8)与乳腺癌的发生和发展有关,在乳腺癌中其水平经常升高。驱动FGF-8介导的肿瘤发生的机制尚不完全清楚。在本文中,我们旨在通过对FGF-8b处理的雌激素受体阴性S115乳腺癌细胞在各个时间段内与表达的那些基因进行比较的cDNA微阵列分析,来鉴定与FGF-8b介导的乳腺癌细胞增殖相关的靶基因。在未处理的细胞中。分别通过qPCR和western印迹验证所选基因的基因和蛋白质表达。此外,使用TRANSBIG数据,FGF-8调控基因的人类直系同源基因的表达与诺丁汉预后指数和雌激素受体状态相关。分析显示,在所有治疗时间中,对FGF-8b都有大量明显上调和下调的基因。表达差异最大的基因是与细胞周期调控,有丝分裂,癌症和细胞死亡有关的基因。几个早期细胞周期进展的关键调控因子,例如Btg2和cyclin D1,以及有丝分裂调控因子,包括cyclin B,Plk1,survivin和Aurora激酶A,被确定为FGF-8b的新靶标,其中一些还额外证明与人类乳腺癌的预后和ER状态相关。结果表明,在增殖刺激中,FGF-8b不仅可以促进细胞通过G1限制点的进程,而且还可以调节乳腺癌细胞在有丝分裂和胞质分裂过程中参与染色体分离的关键蛋白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号